55304-80-8

Basic information

• Product Name: 2,6-Dibromo-3-nitropyridine
• Synonyms: 2,6-DIBROMO-3-NITRO-PYRIDINE;2,6-Dibromo-3-Nitropridine;2,6-dibromo-3-nitro-pryridine;2,6-Dibromo-3-nitropyridine ,98%
• CAS NO: 55304-80-8
• Molecular Formula: C₅H₂Br₂N₂O₂
• Molecular Weight: 281.89
• Product Categories: Pyridines;Pyridine;Heterocycle-Pyridine series
• Mol File: 55304-80-8.mol
• Article Data: 9

Chemical Properties

• Melting Point: 78 °C
• Boiling Point: 295.8 °C at 760 mmHg
• Flash Point: 132.7 °C
• Appearance: /
• Density: 2.221 g/cm³
• Storage Temp.: Inert atmosphere,Room Temperature
• Solubility: DMSO (Slightly), Methanol (Slightly)
• PKA: -7.68±0.10(Predicted)
• CAS DataBase Reference: 2,6-Dibromo-3-nitropyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-Dibromo-3-nitropyridine(55304-80-8)
• EPA Substance Registry System: 2,6-Dibromo-3-nitropyridine(55304-80-8)

Safety Data

• Hazard Codes: Xi
• Safety Statements: 24/25
• Hazardous Substances Data: 55304-80-8(Hazardous Substances Data)

Usage

Description

2,6-Dibromo-3-nitropyridine is a chemical compound characterized by its yellow powder form. It is a derivative of pyridine, a basic nitrogen-containing structure, with two bromine atoms at the 2nd and 6th positions and a nitro group at the 3rd position. 2,6-Dibromo-3-nitropyridine is known for its utility in various chemical processes and organic synthesis.

Uses

Used in Pharmaceutical Industry:
2,6-Dibromo-3-nitropyridine is used as a reagent for the synthesis of amino(carbamoylmethyl) pyridones, which are important as factor VIIa inhibitors and anticoagulants. These compounds play a significant role in the development of medications aimed at treating conditions related to blood clotting and coagulation disorders.
Used in Organic Synthesis:
In the field of organic chemistry, 2,6-Dibromo-3-nitropyridine serves as a valuable reagent for a range of chemical processes. Its unique structure allows it to participate in various reactions, making it a versatile component in the synthesis of different organic compounds.

Upstream product

• 626-05-1 2,6-Dibromopyridine 
• 16013-85-7 2,6-dicholoro-3-nitropyridine 

Downstream Products

• 618398-61-1 [6-(3-amino-5-nitrophenyl)-3-(isopropylamino)-2-oxopyridin-1(2H)-yl]acetic acid 
• 618398-57-5 [6-{3-[(benzyloxy)carbonyl]-5-nitrophenyl}-3-(isopropylamino)-2-oxopyridin-1(2H)-yl]acetic acid 
• 374784-55-1 tert-butyl [6-{3-[(tert-butoxycarbonyl)amino]-5-nitrophenyl}-3-(isopropylamino)-2-oxopyridin-1(2H)-yl]acetate 
• 618398-49-5 benzyl 3-[1-(2-tert-butoxy-2-oxoeth-1-yl)-5-(isopropylamino)-6-oxo-1,6-dihydropyridin-2-yl]-5-nitrobenzoate 
• 618398-72-4 benzyl (1E)-amino{4-[({[6-(3-amino-5-nitrophenyl)-3-(isopropylamino)-2-oxopyridin-1(2H)-yl]acetyl}amino)methyl]phenyl}methylenecarbamate 
• 618398-67-7 benzyl 3-[1-(2-{[4-((E)-amino{[(benzyloxy)carbonyl]imino}methyl)benzyl]amino}-2-oxoethyl)-5-(isopropylamino)-6-oxo-1,6-dihydropyridin-2-yl]-5-nitrobenzoate 
• 618398-72-4 benzyl (1E)-amino{4-[({[6-(3-amino-5-nitrophenyl)-3-(isopropylamino)-2-oxopyridin-1(2H)-yl]acetyl}amino)methyl]phenyl}methylidenecarbamate 
• 618398-67-7 benzyl 3-[1-(2-{[4-((E)-amino{[(benzyloxy)carbonyl]imino}methyl)benzyl]amino}-2-oxoethyl)-5-(isopropylamino)-6-oxo-1,6-dihydropyridin-2-yl]-5-nitrobenzoate 
• 84487-04-7 6-bromo-3-nitro-pyridin-2-ylamine 
• 1224321-68-9 6-bromo-3-nitro-2-(trifluoromethyl)pyridine 
• 1201824-91-0 C₉H₈Br₂N₂ 
• 1254171-34-0 6-bromo-N-(4-methoxybenzyl)-3-nitropyridin-2-amine 
• 1314531-24-2 (6'-bromo-3'-nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-yl)-acetic acid ethyl ester 
• 1314530-63-6 N-[4-(tert-butylcarbamoyl-methyl)-6'-methanesulfonyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3'-yl]-3-chloro-benzamide 

Relevant articles and documents

3-SUBSTITUED IMIDAZO (4, 5-B) PYRIDINES AND ANALOGS AS SIRTUIN MODULATORS

Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for e

Evaluation of basic, heterocyclic ring systems as templates for use as potassium competitive acid blockers (pCABs)

A variety of basic, heterocyclic templates has been reported as potassium-competitive, acid pump antagonists. Herein, we report a comparison of potencies of these templates and others to establish which offers the best start point for further systematic o

PYRIDINE METHYLENE AZOLIDINONES AND USE THEREOF PHOSPHOINOSITIDE INHIBITORS

-